Advanced company searchLink opens in new window

BARCLAY PHARMACEUTICALS LIMITED

Company number 02770716

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
22 Jul 2024 CH01 Director's details changed for Mrs Wendy Margaret Hall on 28 June 2024
22 Jul 2024 PSC05 Change of details for Aah Pharmaceuticals Limited as a person with significant control on 28 June 2024
28 Jun 2024 AD01 Registered office address changed from Sapphire Court Walsgrave Triangle Coventry CV2 2TX to The Woods Haywood Road Warwick CV34 5AH on 28 June 2024
11 Apr 2024 AA Audit exemption subsidiary accounts made up to 31 March 2023
11 Apr 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 31/03/23
11 Apr 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 31/03/23
11 Apr 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 31/03/23
12 Feb 2024 CS01 Confirmation statement made on 25 January 2024 with updates
01 Feb 2024 AP01 Appointment of Adrian Mark Stubbings as a director on 1 February 2024
01 Feb 2024 TM01 Termination of appointment of James Ian Clarke as a director on 31 January 2024
01 Feb 2024 TM01 Termination of appointment of Robin Lindsay Dargue as a director on 31 January 2024
19 Sep 2023 AP01 Appointment of Mr James Ian Clarke as a director on 14 September 2023
11 Sep 2023 PSC07 Cessation of Admenta Holdings Limited as a person with significant control on 25 August 2023
11 Sep 2023 PSC02 Notification of Aah Pharmaceuticals Limited as a person with significant control on 25 August 2023
05 Sep 2023 MR01 Registration of charge 027707160011, created on 1 September 2023
29 Aug 2023 SH19 Statement of capital on 29 August 2023
  • GBP 25,000
29 Aug 2023 RESOLUTIONS Resolutions
  • RES06 ‐ Resolution of reduction in issued share capital
29 Aug 2023 CAP-SS Solvency Statement dated 29/08/23
29 Aug 2023 SH20 Statement by Directors
22 Aug 2023 MR04 Satisfaction of charge 027707160004 in full
22 Aug 2023 MR04 Satisfaction of charge 027707160005 in full
22 Aug 2023 MR04 Satisfaction of charge 027707160006 in full
22 Aug 2023 MR04 Satisfaction of charge 027707160007 in full
22 Feb 2023 AA Full accounts made up to 31 March 2022
25 Jan 2023 CS01 Confirmation statement made on 25 January 2023 with updates